10月19日，佑驾创新（02431.HK）公告称，近日正式收到中标通知书，确认成为桐乡市车路云一体化城市交通融合感知项目（2025年自动驾驶公交车采购项目）的中标单位，中标金额达1185万元（人民币，下同）。公司称，该项目标志着公司在L4级自动驾驶商业化进程中取得关键突破，进一步巩固公司在智慧城市与智能交通领域的领先地位 ...

Debt has become a substantial burden for developing countries due to limited access to financing, rising borrowing costs, currency devaluations and sluggish growth. These factors compromise the ...

Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that clinical data from Stage A of a Phase 3 study in China sponsored ...

The deal, pending regulatory approvals, would give Ripple access to large enterprise clients as it is building out financial ...

Create a MotoGP™ account now and gain access to exclusive content, such as the MotoGP™ Newsletter, which features GP Reports, incredible videos and other interesting information about our sport.

Fintel reports that on October 15, 2025, Baird upgraded their outlook for Vor Biopharma (NasdaqGS:VOR) from Neutral to ...

Investing.com - 贝尔德 (Baird)周二将 Vor Biopharma, Inc. (NASDAQ:VOR) 的评级从"中性"上调至"优于大市"，同时大幅提高其目标价，从20.00美元上调至64.00美元。根据 InvestingPro 数据，该股票在过去六个月内已上涨超过120%，目前基于全面的公允价值分析显示其被低估。

Vor Biopharma Inc (NASDAQ:VOR) rose 3.8% in premarket trading Tuesday after its partner RemeGen announced encouraging 48-week ...

Investing.com -- Vor Biopharma Inc (NASDAQ:VOR) stock gained 3.8% in premarket trading Tuesday after its collaborator RemeGen reported positive 48-week results from a Phase 3 study of telitacicept in ...

Investing.com -- Vor Biopharma Inc (NASDAQ:VOR) 股价在周二盘前交易中上涨3.8%，此前其合作伙伴荣昌生物 (RemeGen)报告了telitacicept在原发性干燥综合征三期研究中的48周积极结果。

美军费近万亿，为何士兵军饷成问题？美军130万名现役军人，军饷怎么领？